medigraphic.com

2003, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2003; 41 (5)

Basic Concepts in Epidemiology and Statistics. A Neurologist’s View

Aguilar RF, Juárez OSJ, Mejía AJM, Zanabria SM

Language: Spanish
References: 20
Page: 419-427
PDF size: 312.43 Kb.


ABSTRACT

Annual incidence for disease and injury of the nervous system is approximately 2.5 % (2500 per 100 000) and prevalence is approximately 9.5 % in the U.S., according to the National Institutes of Health. Nevertheless, the neurologist must known the basic elements of epidemiology, wich defined the course of illness and risk factor identification requires specific studies and appropriate statistical testing.


REFERENCES

  1. Sales-Carmona VF. Evaluación de las medidas terapéuticas. Ensayo clínico controlado. En: Moreno-Altamirano L, Cano-Valle F, García-Romero H. Epidemiología clínica. México: McGraw-Hill-Interamericana; 1994. p. 33-51.

  2. Last JM. Dictionary of epidemiology. Third edition. New York, USA: Oxford University Press; 1995. p. 17-18.

  3. Schoenberg BS. Neurological epidemiology. New York, USA: Raven Press; 1991. p. 1-4.

  4. Kurtzke JF. Neuroepidemiology. Ann Neurol 1984;16:265-277.

  5. Wolf PA, Kannel WB, Dawber TR. Prospective investigations: The Framingham study and the epidemiology of stroke. Adv Neurol 1978;19:107-120.

  6. Rothman KJ, Greenland S. Modern epidemiology. Second edition. Philadelphia: Lippincott-Raven Publishers; 1998. p. 21-114.

  7. Ahlbom A, Staffan N. Fundamentos de epidemio-logía. Cuarta edición. México: Siglo XXI; 1993. p. 3-11.

  8. Dos-Santos-Silva I. Epidemiología del cáncer: prin-cipios y métodos. Lyon, Francia: Agencia Inter-nacional de Investigación sobre el Cáncer; 1999.

  9. Silva-García-de-la-Torre G, Huerta-Alvarado SG. Consideraciones metodológicas y análisis simple de los estudios transversales. Bol Med Hosp Infant Mex 1998;55:348-356.

  10. Howe GR, Choi BCK. Methodological issues in case-control studies: validity and power of various design/strategies. Int J Epidemiol 1983;12:238-245.

  11. Lascano-Ponce E, Salazar-Martínez E, Hernández- Ávila M. Estudios epidemiológicos de casos y con-troles. Fundamento teórico, variantes y aplica-ciones. Salud Publica Mex 2001;43:135-150.

  12. Rodríguez L, Kirwood BR. Case controls designs in the study of common diseases: updates on the demise of rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990;19:205-213.

  13. Aguilar-Rebolledo F, Cedillo R, Velásquez FR, Enciso A, Llaguno P, Rayo D, Torres J, Garza S, Vélez Z, Muñoz O. Factores de riesgo intrafamiliar para la adquisición de la neurocisticercosis sintomática en niños. Décimo Foro Nacional de Investigación en Salud, Instituto Mexicano del Seguro Social, Cocoyoc, Morelos, 25-28 de septiembre de 2001: 281.

  14. Riedmann P. Conceptos prácticos en investigación clínica. El clínico y los estudios de cohortes. Rev Mex Reumatol 1992;7:105-107.

  15. Guyatt GH, Seller JL, Jaeshke R. The n-of-1 rando-mized controlled trial: clinical usefulness. Ann Inter Med 1990;112:293-299.

  16. Maclure M. The case-crossover designs: A method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-153.

  17. Johannessen T. Controlled trial in single subjects. Br Med J 1991;303:173-174.

  18. Aguilar-Rebolledo F, Rayo-Mares D, Hernández- Sánchez J, Ruiz-Ponce J, Garrido E. Botulinum toxin as a treatment for spasticity and dystonia in pediatric cerebral palsy. Gac Med Mex 2001;137(5):403-411.

  19. Sugarman J. Ethics in the design and conduct of cli-nical trials. Epidemiol Rev 2002;24:54-58.

  20. Cowan LD, Leviton A, Dammann O. New research directions in neuroepidemiology (diseases and health problems). Epidemiol Rev 2000;22:18-23.




2020     |     www.medigraphic.com